News

Topiramate, also sold under the brand name Topamax, is a drug approved by the U.S. Food and Drug Administration (FDA) for ...
Patients who take a common drug for high blood pressure are being urged to check the medication after its manufacturer reported that a mistake in the strength of the dose had been printed on some ...
It comprised children with intractable epilepsy who had received a mean of eight antiepileptic drugs and in whom topiramate was added to a median of two antiepileptic drugs. Clinical follow-up ...
OBJECTIVE: To examine the safety and effectiveness of topiramate as add-on therapy for the management of combat-related PTSD and to examine the effects of topiramate on sleep and alcohol consumption.
Now, let's get to the news: Blue Cross Blue Shield of Massachusetts, the state's largest commercial health insurer, is rolling back its coverage of GLP-1 drugs like Ozempic and Wegovy for weight loss.
9. Sodium-Glucose Cotransporter-2 Inhibitors Sodium-glucose cotransporter-2 (SGLT2) inhibitors were originally developed as a medication to help manage type 2 diabetes. Research has shown that they ...
Topamax (topiramate) is a prescription drug used for preventing migraine episodes and treating seizures in people with epilepsy. Topamax comes as a tablet or sprinkle capsule. It belongs to a ...
Years later, Becca used that same smartphone to purchase drugs from dealers on social media. On September 16, 2020, the 18-year-old died from drug poisoning after ingesting fentanyl-laced cocaine ...
“Major” tariffs on pharmaceutical imports are coming soon, President Donald Trump says, pledging that they’d help bring drug manufacturing back to the US while lamenting that other countries ...
Kennedy Jr. spoke with CBS News chief medical correspondent Dr. Jon LaPook about a range of topics, including measles, food additives and weight loss drugs. Here are some highlights from their ...
A midwife caught on camera repeatedly stealing medication while on duty at Antrim Area Hospital has been barred from the nursing profession. Donna McGreevey (55) hit the headlines earlier this ...
The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors, representing an innovative approach to metabolic health. Prices range from Rs3,500 to Rs4,375 per vial.